Pharmaceuticals

CAM2038 Opioid dependence US
Phase 3

CAM2038 Opioid dependence Europe
Phase 3

CAM2038 q1w Chronic pain
Phase 3

CAM2038 q4w Chronic pain
Phase 3

CAM2029 Neuroendocrine tumors
Phase 1-2

CAM2029 Acromegaly
Phase 1-2

CAM2032 Prostate cancer
Phase 1-2

CAM2047 CINV¹
Phase 1-2

CAM2048/2058 Postoperative pain & PONV²
Phase 1-2

CAM4071 Undisclosed indication
Phase 1-2

CAM4072 Genetic obesity
Phase 1-2

CAM2043 PAH³
Preclinical

1) Chemotherapy induced nausea and vomiting, 2) Postoperative nausea and vomiting. 3) Pulmonary arterial hypertension.

Medical device

episil® Oral mucositis
Market